UBS analyst Dan Leonard reiterated a Buy rating and $285.00 price target on West Pharmaceutical (NYSE: WST).The analyst commented, "Today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE